Proton Boost in Prostate Cancer

Status Active, not recruiting

Clinical Trial Summary

This study uses photon radiation with a proton boost to treat prostate cancer. The purpose of this study is to determine if proton therapy as a boost following photon intensity modulated radiation therapy (IMRT) produces decreased toxicity as compared to conventional photon IMRT alone in the treatment of prostate cancer. Our secondary objective is to determine the effectiveness of this treatment regimen. Effectiveness will be determined by length of time to progression or recurrence of disease and overall survival. Patients on this study will be treated with a course of photon radiation therapy followed by a boost course of proton radiation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03564275
Study type	Interventional
Source	University of Cincinnati
Contact
Status	Active, not recruiting
Phase	N/A
Start date	April 16, 2018
Completion date	April 2033

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03653819` - High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs	N/A
Withdrawn	`NCT05191017` - Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC	Phase 1/Phase 2
Completed	`NCT00970203` - Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer	Phase 2
Not yet recruiting	`NCT06363266` - A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers	N/A
Active, not recruiting	`NCT02003924` - Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer	Phase 3
Completed	`NCT00643617` - CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry	N/A
Completed	`NCT00844792` - Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer	Phase 2
Completed	`NCT01303705` - Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer	Phase 1
Completed	`NCT02578940` - Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer	Phase 3
Completed	`NCT04057859` - PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training
Completed	`NCT00564928` - A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer	Phase 2
Completed	`NCT02958787` - Vessel Sparing Prostate Radiation Therapy	Phase 2
Completed	`NCT01897207` - Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer	Phase 1/Phase 2
Recruiting	`NCT05241236` - MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
Active, not recruiting	`NCT03939689` - Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone	Phase 2
Completed	`NCT02274350` - The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects	N/A
Completed	`NCT00744549` - Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance	Phase 2
Recruiting	`NCT05252390` - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors	Phase 1/Phase 2
Completed	`NCT02212548` - Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose	N/A
Completed	`NCT04017325` - European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up